In vivo, retatrutide produced significant reductions in body weight, adiposity, and blood glucose levels in diet-induced obese mouse models, outperforming dual GIP/GLP-1 agonists through the additional thermogenic and energy-expenditure effects mediated by glucagon receptor activation
This article explains Retatrutide weight loss results trial data and FDA status, including how it may work, what trial results showed, possible side effects, and why medical guidance matters before starting any weight-loss plan
also found that concentrations of IL11, IL28A, and IL29 were significantly increased in the serum of patients with lipedema (Wolf et al., 2021)
Calibrate provides more direct physician access for urgent concerns, while Noom Med offers 24/7 app-based support with provider follow-up